Active Public Health & Healthcare Infection & Immunity

Africa Health Research Institute - Core Renewal 2023-30 (GBP)

In plain English

AI plain-English summary

A research institute in KwaZulu-Natal, South Africa, is expanding its focus beyond HIV and tuberculosis to tackle adolescent mental health and emerging infectious diseases. The province carries the world’s highest rates of HIV and TB, but these are not the only health crises. Depression and anxiety disorders among adolescents are a major, growing burden locally and globally, yet remain under-researched in African populations. The institute also aims to build on its COVID-19 work to study neglected infections that disproportionately affect under-resourced communities. If successful, the institute’s integrated approach—linking fundamental science, clinical trials, and community-based studies—could produce evidence that directly shapes health policy and clinical practice in South Africa and other low-resource settings. For example, better data on adolescent mental health could lead to school-based screening programmes or affordable treatment protocols. The work is not purely curiosity-driven; it targets specific, actionable health problems. However, much of the fundamental science on pathogen biology and immune responses will generate knowledge whose practical applications may emerge years later, as happened with HIV research that underpinned antiretroviral therapy.

View original technical description
AHRI’s vision is optimal health and well-being of under-resourced populations. We conduct research on important, intractable and intersecting health problems which impact well-being and mortality in South Africa and globally. The highest prevalence of HIV and TB, globally, is in our province; our research on these infections will therefore continue, with new strategic directions. We will introduce research on emerging and neglected infections, building on extraordinary impact of our Covid-19 science. We will build a new research programme in adolescent common mental health disorders, which is a very significant local – and global – health challenge. AHRI is uniquely placed to address these challenges: we focus on research questions for which we have a competitive advantage and exploit our integrated research value chain of basic, translational, clinical, population and social sciences. We will introduce innovation in all these areas, while fostering a research culture of well-being and scientific success. We regard training of the next generation of African scientists as a priority. We cannot achieve success alone – we will nurture academic partnerships and optimise public engagement, particularly with our research communities. Our ultimate goal is impact on scientific knowledge, practice and policy, in South Africa and beyond.

View the original record at the funder ↗

Researchers

Adrie Steyn (EPMC Awardee)Alan Stein (EPMC Awardee)Alexander Sigal (EPMC Awardee)Alison Grant (EPMC Awardee)Ingrid Bassett (EPMC Awardee)Kobus Herbst (EPMC Awardee)Limakatso Lebina (EPMC Awardee)Maryam Shahmanesh (EPMC Awardee)Nothando Ngwenya (EPMC Awardee)Thumbi Ndung'u (EPMC Awardee)Willem Hanekom (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Policy Engagement Award
Africa Health Research Institute (GBP record)
Kemri-Wellcome Trust Research Programme (KWTRP) core funding renewal 2023-2030. (Kenya AAP)
Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
AMS Professorship Award for Professor Helena Legido-Quigley, Imperial College London

Original classification

Africa and Asia Programme Renewal

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.